Clinical Trial Update: Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of liposomal vincristine in patients with refractory or relapsed Non-Hodgkin lymphoma has completed, with results reported for this study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Liposomal vincristine (vincristine liposome)

Snippet

Sponsor: Inex Pharmaceuticals | Conditions: Lymphoma | Phase 2 | Status: COMPLETED